A detailed history of State Board Of Administration Of Florida Retirement System transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 205,289 shares of BMRN stock, worth $13 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
205,289
Previous 209,930 2.21%
Holding current value
$13 Million
Previous $17.3 Million 16.51%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$69.02 - $93.84 $320,321 - $435,511
-4,641 Reduced 2.21%
205,289 $14.4 Million
Q2 2024

Aug 08, 2024

SELL
$74.43 - $92.22 $472,183 - $585,043
-6,344 Reduced 2.93%
209,930 $17.3 Million
Q1 2024

May 08, 2024

BUY
$83.81 - $99.0 $241,708 - $285,516
2,884 Added 1.35%
216,274 $18.9 Million
Q4 2023

Feb 09, 2024

SELL
$76.22 - $98.51 $614,942 - $794,778
-8,068 Reduced 3.64%
213,390 $20.6 Million
Q3 2023

Nov 08, 2023

BUY
$85.07 - $94.48 $25,350 - $28,155
298 Added 0.13%
221,458 $19.6 Million
Q2 2023

Aug 11, 2023

BUY
$86.68 - $100.3 $423,518 - $490,065
4,886 Added 2.26%
221,160 $19.2 Million
Q1 2023

Jun 14, 2023

BUY
$87.74 - $117.27 $175,480 - $234,540
2,000 Added 0.93%
216,274 $21 Million
Q1 2023

May 11, 2023

BUY
$87.74 - $117.27 $175,480 - $234,540
2,000 Added 0.93%
216,274 $21 Million
Q4 2022

Jun 14, 2023

SELL
$80.93 - $108.63 $161,860 - $217,260
-2,000 Reduced 0.92%
214,274 $22.2 Million
Q4 2022

Feb 07, 2023

BUY
$80.93 - $108.63 $172,380 - $231,381
2,130 Added 1.0%
214,274 $22.2 Million
Q3 2022

Nov 08, 2022

SELL
$82.16 - $96.94 $285,095 - $336,381
-3,470 Reduced 1.61%
212,144 $18 Million
Q2 2022

Aug 05, 2022

SELL
$71.48 - $86.85 $906,437 - $1.1 Million
-12,681 Reduced 5.55%
215,614 $17.9 Million
Q1 2022

May 06, 2022

SELL
$74.28 - $92.69 $353,795 - $441,482
-4,763 Reduced 2.04%
228,295 $17.6 Million
Q4 2021

Feb 08, 2022

SELL
$71.72 - $91.47 $178,295 - $227,394
-2,486 Reduced 1.06%
233,058 $20.6 Million
Q3 2021

Nov 08, 2021

SELL
$74.77 - $85.47 $446,451 - $510,341
-5,971 Reduced 2.47%
235,544 $18.2 Million
Q2 2021

Aug 10, 2021

SELL
$75.51 - $84.79 $1.93 Million - $2.17 Million
-25,560 Reduced 9.57%
241,515 $20.2 Million
Q1 2021

May 10, 2021

SELL
$74.73 - $90.69 $862,384 - $1.05 Million
-11,540 Reduced 4.14%
267,075 $20.2 Million
Q4 2020

Feb 08, 2021

BUY
$72.61 - $90.2 $861,154 - $1.07 Million
11,860 Added 4.45%
278,615 $24.4 Million
Q3 2020

Nov 09, 2020

BUY
$71.87 - $131.03 $10,061 - $18,344
140 Added 0.05%
266,755 $20.3 Million
Q2 2020

Aug 07, 2020

BUY
$79.55 - $124.22 $2.15 Million - $3.36 Million
27,031 Added 11.28%
266,615 $32.9 Million
Q1 2020

May 05, 2020

BUY
$71.37 - $96.85 $10,634 - $14,430
149 Added 0.06%
239,584 $20.2 Million
Q4 2019

Feb 03, 2020

SELL
$64.27 - $86.37 $211,448 - $284,157
-3,290 Reduced 1.36%
239,435 $20.2 Million
Q3 2019

Nov 07, 2019

BUY
$67.4 - $85.11 $66,456 - $83,918
986 Added 0.41%
242,725 $16.4 Million
Q2 2019

Aug 05, 2019

SELL
$80.35 - $93.9 $380,216 - $444,334
-4,732 Reduced 1.92%
241,739 $20.7 Million
Q1 2019

May 03, 2019

SELL
$84.2 - $98.62 $54,730 - $64,103
-650 Reduced 0.26%
246,471 $21.9 Million
Q4 2018

Feb 01, 2019

SELL
$80.14 - $106.07 $170,618 - $225,823
-2,129 Reduced 0.85%
247,121 $21 Million
Q3 2018

Oct 31, 2018

SELL
$93.92 - $105.72 $250,202 - $281,638
-2,664 Reduced 1.06%
249,250 $24.2 Million
Q2 2018

Aug 06, 2018

BUY
$76.01 - $99.03 $6,840 - $8,912
90 Added 0.04%
251,914 $23.7 Million
Q1 2018

May 04, 2018

SELL
$77.67 - $92.63 $609,165 - $726,497
-7,843 Reduced 3.02%
251,824 $20.4 Million
Q4 2017

Feb 01, 2018

BUY
$80.76 - $95.13 $38,037 - $44,806
471 Added 0.18%
259,667 $23.2 Million
Q3 2017

Oct 31, 2017

BUY
$80.6 - $94.95 $20.9 Million - $24.6 Million
259,196
259,196 $24.1 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.